Test Your Hypothesis

 BGPT Odds of True

The hypothesis is a two-armed structural question with no supporting data in the supplied records; a neutral 50% prior reflects maximal uncertainty, narrowed slightly toward the structural-constraint arm because conserved charged residues in viral receptor pockets are often mechanically constrained.

 Hypothesis Novelty

Minibinder escape-mechanism redesign for henipavirus entry inhibitors is a specific, contemporary protein-engineering question, but framed around known ephrin-B2/NiV G structural biology rather than a fundamentally new concept.

 Quick Analysis Plan Copied

 Long Analysis Plan

Evidence Gap

The supplied claim-level records do not address the hypothesis. None report structural data on the NiV G receptor pocket, residue arginine 442, mutation R242, minibinder escape, or hydrogen-bond acceptor geometry in the scaffolded Ephrin-B2 G-H loop. Structural claims would require the NiV G–ephrin-B2 complex crystal structure, deep mutational scanning, and escape-variant selection data, none of which appear in the provided sources.

What the records do establish: ephrin-B2 is the functional NiV receptor and its ectodomain (not the cytoplasmic tail) mediates entry, supporting the premise that G-H loop–mimetic binders target a valid site Ephrin-B2 ectodomain suffices for NiV entry. Ephrin-B2–expressing porcine cells enable pseudovirus neutralization assays that could screen minibinder escape phenotypes NiV pseudovirus neutralization platform. However, whether R242-mediated escape can be engineered away, or reflects a structural constraint of conserved arginine 442, remains untested here. Note also an internal inconsistency in the question: R242 and R442 numbering must be verified against a defined NiV G reference sequence before the hypothesis is testable.

Conclusion: The hypothesis is plausible but unevaluated with the supplied evidence; both arms (redesign success vs. structural constraint) remain open.